http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1099641-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1cd6051bf69f25a0652ded4e4edac31
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 1977-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1981-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0208c359e414f73575faddaa755622f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c7484bac8b44a986bbbc2bc480146a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94dfb0eb1a69d70ece51708960ee99e7
publicationDate 1981-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1099641-A
titleOfInvention Pharmaceutical composition containing chromone derivatives
abstract Case 2207 Mixtures ABSTRACT There is described a pharmaceutical composition comprising one or more of 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol; 5-(2-hydroxy-propoxy)-8-propyl-chromone-2-carboxylic acid; 6,7,8,9-tetrahydro-4-oxo-10-propyl-4H-naphtho[2,3-b]pyran-2-carboxylic acid; 6,7,8,9-tetrahydro-5-hydroxy-4-oxo-10-propyl-4H-naphtho-[2,3-b]pyran-2-carboxylic acid; or a pharmaceutically acceptable salt of any one thereof, in combination with one or more of aspirin, indomethacin, phenylbutazone or oxyphenbutazone. There are also described packages containing the separate components of the composition and pharmaceutical formulations containing the composition.
priorityDate 1977-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415821828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454733511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448762104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11970596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425539605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13541300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421210339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22418719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3085184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448969875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450159460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966732

Total number of triples: 53.